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Role of Bcl-xL in paracetamol-induced tubular epithelial cell
death.
Background. Paracetamol overdose causes acute renal fail-
ure and chronic exposure to paracetamol has been linked
to chronic renal failure. Recently, apoptosis induction has
been identified as a possible mechanism of paracetamol
nephrotoxicity.
Methods. Murine proximal tubular epithelial MCT cells were
cultured in the presence of paracetamol. The effects of Bcl-
xL overexpression, Bax antisense oligodeoxynucleotides, and
different caspase inhibitors on cell death were studied.
Results. While paracetamol did not change the mRNA ex-
pression of the antiapoptotic gene bcl-xL, it decreased Bcl-xL
protein levels. The decrease in Bcl-xL was prevented by lac-
tacystin, but not by caspase inhibitors. Addition to the culture
media of the survival factors present in fetal calf serum (FCS) in-
creased Bcl-xL expression and decreased paracetamol-induced
apoptosis. Overexpression of a human bcl-xL transgene de-
creased apoptosis induced by paracetamol by 60% at 24 hours
and increased long-term cell survival. The constitutive expres-
sion of the viral caspase inhibitor CrmA decreased the rate of
apoptosis by 60% at 24 hours and the broad-specific caspase
inhibitor zVAD-fmk prevented paracetamol-induced features
of apoptosis. However, caspase inhibitors did not prevent even-
tual cell death. Bax did not translocate to mitochondria and Bax
antisense oligodeoxynucleotides were not protective.
Conclusion. Our results suggest that induction of apopto-
sis may underlie the nephrotoxic potential of paracetamol and
identify Bcl-xL as a player in toxic tubular cell injury.
Paracetamol is an over-the-counter analgesic with
nephrotoxic potential [1–6]. Paracetamol overdose is a
cause of acute liver and renal failure in humans and ex-
perimental animals [2, 3, 7]. Acute nephrotoxicity by
paracetamol is characterized by morphologic and func-
tional (phosphaturia, low-molecular-weight proteinuria)
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evidence of proximal tubular injury in humans and exper-
imental animals [2, 3, 7]. Acute renal failure in the course
of therapeutic paracetamol administration has also been
described in alcoholics [3]. In addition, a chronic nephro-
toxic effect of paracetamol is suggested by case-control
studies [4–6]. These findings have led to the recommen-
dation that paracetamol be used in limited amounts and
for limited time periods, pending definitive confirmation
of its nephrotoxic potential [8]. Research into the biologic
basis of paracetamol nephrotoxicity has been encouraged
by a National Kidney Foundation Ad Hoc Committee
[8].
Tubular cell loss is a characteristic feature of both acute
renal failure and chronic renal disease (reviewed in [9]).
Tubular cell loss is observed when cell death predom-
inates over mitosis. Apoptosis is an active form of cell
death that offers the opportunity for therapeutic inter-
vention [9, 10]. Paracetamol promotes hepatocyte and
renal tubular cell apoptosis [11, 12]. In renal proximal
tubular epithelial cells, paracetamol activates caspases-9
and -3. In addition there is evidence for the involvement
of endoplasmic reticulum injury, including GADD153
translocation to the nucleus and proteolysis of caspase-
12 [12]. Several endogenous proteins protect mammalian
cells from apoptosis. One of the most important is
Bcl-xL, a member of the Bcl-2 family [13]. Bcl-xL pro-
tects cells from a wide variety of apoptotic stimuli [13],
and has recently been shown to be regulated in the course
of nephrotoxic acute renal failure [14]. However, Bcl-xL
does not offer protection, in a cell-specific fashion, against
certain stimuli, such as death receptor–mediated apop-
tosis [15, 16]. Moreover, caspase-generated Bcl-xL frag-
ments are proapoptotic [17]. The role of Bcl-xL in
protection form nephrotoxic drugs had not been previ-
ously addressed.
Tubular cell injury is the main feature observed during
paracetamol-induced renal failure both in humans and
animal models [2, 3]. Because expression of the protective
protein Bcl-xL has been shown to be regulated in tubular
cells during experimental toxic acute renal failure [14], we
investigated the role of Bcl-xL in paracetamol-induced
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apoptosis of cultured mouse renal proximal tubular
epithelial cells.
METHODS
Cell lines and cell culture
MCT cells are a cultured line of proximal tubular ep-
ithelial cells harvested originally from the renal cortex of
SJL mice [18]. The cells were maintained in culture in
RPMI 1640 (Gibco, Grand Island, NY, USA), 10% heat-
inactivated fetal calf serum (FCS), 2 mmol/L glutamine,
100 U/mL penicillin, and 100 lg/mL streptomycin, at 37◦C
in 5% CO2, as previously described [18]. Human kidney
2 (HK-2) cells, an immortalized human proximal tubular
epithelial cell line (ATCC, Rockville, MD, USA) were
grown on the same media as the MCT cells plus 5 lg/mL
insulin, 5 lg/mL transferrin, 5 ng/mL sodium selenite,
and 5 ng/mL hydrocortisone. For experiments on the ef-
fect of paracetamol, cells were plated and then grown for
24 hours in RPMI-10% FCS. Then the media was replaced
with fresh serum-free RPMI (RPMI-0%), unless other-
wise stated. RPMI-0% contained the same supplements
as the serum-supplemented RPMI with the exception of
the FCS. A concentration of 300 lg/mL paracetamol was
chosen for studies on the intracellular pathways of cell
death because it is in the range found in clinical paraceta-
mol intoxication and readily induces apoptosis in murine
proximal tubular cells [12].
MCT cell lines constitutively expressing Bcl-xL, CrmA,
or control vectors were established. Bcl-xL overexpress-
ing MCT cells express two- to threefold more Bcl-xL than
control vector–transfected cells and the rate of prolifera-
tion is slightly slower than control [14]. MCT cell lines sta-
bly overexpressing CrmA, cloned into pcDNA3.1, were
a gift from T.M. Danoff (University of Pennsylvania) and
E.G. Neilson (Vanderbilt University).
The following caspase inhibitory peptides were used:
the caspase-3 inhibitor, Z-Asp(OMe)-Glu(OMe)-Val-
DL-Asp(OMe)-fluoromethylketone (DEVD-fmk), and
the pancaspase inhibitor, Z-Val-Ala-DL-Asp-fluoro-
methylketone (zVAD-fmk), from Bachem (Bubendorf,
Switzerland), the caspase-8 inhibitor, Z-Ile-Glu(OMe)-
Thr-Asp(OMe)-fluoromethylketone (IETD-fmk), the
caspase-9 inhibitor, Z-Leu-Glu(OMe)-His-Asp(OMe)-
fluoromethylketone (LEHD-fmk), and the irreversible
caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp-Val-
Ala-Asp-fluoromethyl ketone (z-VDVAD-fmk), from
Calbiochem (San Diego, CA, USA). The caspase in-
hibitory peptides were dissolved in dimethyl sulfoxide
(DMSO) and used at concentrations previously shown to
protect from apoptosis in MCT cells or other cell systems
[19]. Final concentration of DMSO was 0.05% and it
did not influence MCT cell apoptosis [19]. Peptides or
the proteasome inhibitor lactacystin (10 lmol/L) (Sigma
Chemical Co., St. Louis, MO, USA) were added to the
cell culture 3 hours prior to paracetamol.
Assessment of apoptosis
For quantification of cell death, 10,000 cells were
seeded in 24-well plates (Costar, Schiphol-Rijk, The
Netherlands) in RPMI-10%, and after 24 hours the cells
where rested in RPMI-0% FCS for 24 hours. Thereafter,
the cells were grown with the indicated stimuli in the
latter medium. At defined time points, the cells were har-
vested from the wells. The nonadherent cells were pooled
with the adherent cells, which were detached from the
plate by gentle trypsinization. Apoptosis was quantified
by flow cytometry analysis of DNA content in permeabi-
lized, propidium iodide–stained cells, as previously de-
scribed [20]. The percentage of cells with decreased DNA
staining (A0), comprising apoptotic cells with fragmented
nuclei, was counted. For expression of specific protection
from paracetamol-induced apoptosis, apoptosis induced
under control conditions (serum-free media with vehicle)
was subtracted from apoptosis in the presence of parac-
etamol. Apoptosis in the presence of paracetamol alone
was considered to be 100% and apoptosis in the pres-
ence of caspase inhibitor or Bcl-xL overexpression was
expressed as a percentage of this [14].
To assess for the pyknotic nuclear changes seen in
apoptosis, cells were plated onto LabtekTM slides (Nunc
Inc, Naperville, IL, USA) in RPMI-10%. After 24 hours
the media was changed to RPMI-0% and then grown for
an additional 48 hours in the presence of paracetamol or
vehicle. The cells were fixed in 10% buffered formalin
and stained with hematoxylin-eosin.
Colony-forming assay
The capacity of cells to survive and divide was as-
sessed by a colony-forming assay. MCT cells were
seeded in 12-well-plates and stimulated for 48 hours
with 300 lg/mL paracetamol in the presence or absence
of 200 lmol/L zVAD-fmk and others. They were then
detached with trypsin-ethylenediaminetetraacetic acid
(EDTA), washed in phosphate-buffered saline (PBS),
seeded in Petri dishes and cultured in 10% FCS-RPMI
for 7 days. They were then fixed in 5% formaldehyde/PBS
and stained with 0.5% crystal violet/20% methanol for
2 minutes before being washed with water and pho-
tographed [19].
Northern hybridization
For Northern blotting, 30 lg of total RNA were sepa-
rated in 1% agarose gels containing 2.3% formaldehyde
[21]. RNA was transferred to nylon membranes (Gene-
screen Plus) (NEN, Perkin Elmer, Zaventem, Belgium)
and prehybridized and hybridized at 65◦C in 6× standard
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saline citrate (SSC), 5× Denhardts, 10% dextran sulfate,
1% sodium dodecyl sulfate (SDS), 100 lg/mL salmon
sperm DNA, and 100 lg/mL polyadenylic acid. The
probes were labeled by random priming and added to
the hybridization solution to a final activity of 1.5 × 106
cpm/mL. After hybridization, blots were washed twice
in 2× SSC for 15 minutes at room temperature, once in
2× SSC and 2% SDS for 45 minutes at 65◦C, and once in
0.1× SSC and 0.1% SDS for 15 minutes at 65◦C. The blots
were then exposed to film at −70◦C with the use of an in-
tensifying screen. Blots were stripped and subsequently
rehybridized with the probe for the housekeeping genes
G3PDH or 28S, to account for small loading or trans-
fer variations. Autoradiograms were quantified using a
GS-800 Calibrated Densitometer and Quantity One 4.4.0
software (Bio-Rad, Hercules, CA, USA), and the results
expressed as arbitrary densitometry units related to the
expression of 28S. The probes for bax and bcl-xL have
been described [14].
Flow cytometry analysis of Bcl-x expression
For cytofluorography, cells were cultured in the pres-
ence of control medium or paracetamol. After wash-
ing the culture with PBS, adherent cells were detached
with 2.2 mmol/L EDTA, 0.2% bovine serum albumin
(BSA) in PBS, and 5 × 105 cells. Single cell suspensions
were fixed in 2% glutaraldehyde/PBS, washed in per-
meabilization buffer (0.01% saponin, FCS), incubated
with 2 lg/mL polyclonal anti-Bcl-xS/L antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) in perme-
abilization buffer for 30 minutes at 4◦C, followed by
incubation with 1:100 fluorescein isothiocyanate (FITC)-
goat-antirabbit IgG for 30 minutes at 4◦C. Control sam-
ples were stained with an anti-BclxS/L antibody which
had been previously incubated with a control Bclx pep-
tide or with nonimmune rabbit IgG. Cells were then
analyzed on a cytofluorograph. Dead cells and debris
were excluded from analysis by selective gating based on
anterior and right-angle scatter. At least 10,000 events
were collected for each sample, and data were displayed
on a logarithmic scale of increasing green fluorescence
intensity.
Western blot
Tissue or cell samples were homogenized in lysis buffer
[50 mmol/L Tris HCl, 150 mmol/L NaCl, 2 mmol/L
EDTA, 2 mmol/L ethyleneglycol tetraacetate (EGTA),
0.2% Triton X-100, 0.3% NP-40, 0.1 mmol/L phenyl-
methylsulfonyl fluoride (PMSF), and 1 lg/mL pepstatin
A] then separated by 12% SDS-polyacrylamide gel elec-
trophoresis (PAGE) under reducing conditions. After
electrophoresis, samples were transferred to polyvinly-
dine difluoride (PVDF) membranes (Millipore Corp.,
Bedford, MA, USA), blocked with 5% skimmed milk
in PBS/0.5% vol/vol Tween 20 for 1 hour, washed with
PBS/Tween, and incubated with rabbit polyclonal anti-
BclxS/L (1:500) (Santa Cruz Biotechnology) or rabbit
polyclonal anti-Bax antibodies (1:2000) (Pharmingen,
San Diego, CA, USA), as described [14]. Antibodies were
diluted in 5% milk PBS/Tween. Blots were washed with
PBS/Tween and subsequently incubated with horseradish
peroxidase-conjugated anti-rabbit IgG (1:2000) (Amer-
sham, Aylesbury, UK). After washing with PBS/Tween
the blots were developed with the enhanced chemilu-
minescence method (ECL) following the manufacturer’s
instructions (Amersham). Blots were then probed with
antitubulin antibody and levels of expression were cor-
rected for minor differences in loading.
Confocal analysis of Bax translocation
Cells were plated onto LabtekTM slides in RPMI-10%.
After 24 hours, the medium was changed to RPMI-0%
for 24 hours and then cells were incubated for 24 hours
with the indicated stimuli. Then, cells were fixed in 4%
paraformaldehyde and permeabilized in 0.2% Triton X-
10 in PBS for 10 minutes each. After washing in PBS,
cells were incubated overnight at 4◦C with a rabbit
polyclonal anti-Bax antibody (1:100) (Santa Cruz
Biotechnology), followed by 1-hour incubation with
appropriate FITC secondary antibody (1:200) (Sigma
Chemical Co.). Cell nuclei were counterstained with pro-
pidium iodide.
Bax antisense oligonucleotide
A phosphorothionate-modified antisense oligodeoxy-
nucleotide (ODN) 5′-TGCTCCCCGGACCCGTCCAT-
3′ directed against the translation initiation region of
mouse Bax mRNA and a control scrambled ODN
5′-TCGTCCGGCCACCGCTCACT-3′, which has little
complementarity with Bax mRNA but the same compo-
sition as the antisense ODN, were synthesized commer-
cially (Metabion GmbH, Martinsried, Germany) [22].
Cells were treated with 300 lg/mL paracetamol in the
presence or absence of Bax antisense ODN (20 lg/mL)
or scramble ODN (20 lg/mL) [19, 21].
Statistical analyses
Results are expressed as mean ± SEM. Significance
at the 95% level was established using one-way anal-
ysis of variance (ANOVA) and Student t test. The
presence of significant differences between groups was
examined by a post hoc test (Bonferroni’s method) by
means of the SigmaStat statistical software (Jandel, San
Rafael, CA, USA). Data represent three independent
experiments.
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RESULTS
Bcl-xL protein expression is down-regulated
in paracetamol-treated tubular epithelial cells
We investigated the participation of Bcl-xL in
paracetamol-induced apoptosis. A paracetamol concen-
tration of 300 lg/mL was chosen for these experiments
because it readily induces apoptosis in cultured tubular
cells and it is in the range found in the serum of patients
with clinically significant paracetamol intoxication [12,
23]. Incubation with 300 lg/mL paracetamol did not sig-
nificantly modify bcl-xL mRNA expression, as assessed
by Northern blot, in MCT cells (Fig. 1A). However, parac-
etamol decreased the expression of Bcl-xL protein by
50% to 60% at 24 hours and 48 hours, as assessed by
flow cytometry (Fig. 1B) and Western blot (Fig. 1C). No
change in Bcl-xL protein expression was noted at earlier
time points (8 hours, data not shown) when no increase
in the rate of apoptosis was evident [12]. The proapop-
totic splice isoform, Bcl-xS, was not detected in control
or paracetamol-treated MCT cells (Fig. 1C).
To discard the hypothesis that paracetamol-induced
changes in Bcl-xL protein and mRNA expression were
cell line-specific we performed similar experiments on the
human proximal tubular epithelial cell line HK-2 that is
also sensitive to paracetamol-induced cell death (data not
shown). There was not a major change in bcl-xL mRNA
expression (Fig. 2A). We also found that paracetamol
decreased Bcl-xL protein expression in HK-2, and the
proapoptotic splice isoform, Bcl-xS, was not detected in
control or paracetamol-treated HK-2 cells (Fig. 2B).
It has been previously published that caspases are capa-
ble of cleaving Bcl-xL into fragments with proapoptotic
activity [17]. However, caspase inhibition did not pre-
vent the fall in Bcl-xL expression in MCT cells treated
with paracetamol (Fig. 1C). By contrast, the highly spe-
cific proteasome inhibitor lactacystin partially prevented
the fall in Bcl-xL expression (Fig. 3A). In addition, lacta-
cystin decreased the percentage of hypodiploid cells in-
duced by paracetamol by approximately 50% at 24 hours
(Fig. 3B). Serum, a stimulus that increased Bcl-xL protein
expression [14], also protects from paracetamol-induced
apoptosis (specific apoptosis induced by paracetamol in
the presence of 10% FCS was 38% ± 12% of the value
obtained under serum free conditions) (P < 0.05).
Overexpression of Bcl-xL protects tubular epithelial cells
against paracetamol-induced apoptosis
To further delineate the role of Bcl-xL in paracetamol-
induced apoptosis, Bcl-xL was stably overexpressed in
transfected MCT cells (Fig. 4A and B). Cells stably over-
expressing Bcl-xL were protected form features of apop-
tosis induced by paracetamol (Fig. 4C), including when
cells where incubated in the presence of high doses of
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Fig. 1. Modulation of Bcl-xL expression in MCT paracetamol-treated
cells. (A) Bcl-xL mRNA expression of paracetamol-treated MCT cells
(300 lg/mL for 6 to 48 hours). Data were normalized for 28S expres-
sion. Diagram represents mean ± SEM of two experiments with sam-
ples done in duplicate. P > 0.5 versus all groups. (B) Paracetamol (300
lg/mL, 48 hours) decreases Bcl-xL protein levels in MCT cells as as-
sessed by flow cytometry. Mean cell fluorescence decreased by 50% in
paracetamol-treated cells. Control is nonimmune rabbit IgG. (C) Parac-
etamol (300 lg/mL, 24 hours) decreases Bcl-xL protein level in MCT
cells as assessed by Western blot. The decrement in Bcl-xL expression
is not prevented by inhibition of caspases with 200 lmol/L zVAD-fmk.
Bcl-xS is not detected in MCT cells. Data are representative of three
experiments. ADU is arbitrary densitometry units.
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Fig. 2. Modulation of Bcl-xL expression in human kidney-2 (HK-
2) paracetamol-treated cells. (A) Bcl-xL mRNA expression of
paracetamol-treated HK-2 cells (300 lg/mL for 6 to 48 hours). Data
were normalized for 28S expression. (B) Paracetamol (300 lg/mL) de-
creases Bcl-xL protein expression in HK-2 cells as assessed by Western
blot. Data were normalized for tubulin expression. ADU is arbitrary
densitometry units.
paracetamol (1000 lg/mL) or during long incubation pe-
riods (48 hours).
Certain inhibitors of caspases prevent features
of apoptosis induced by paracetamol
zVAD-fmk, a broad-spectrum inhibitor of caspases,
prevented features of apoptosis induced by paracetamol
such as internucleosomal DNA degradation or the pres-
ence of hypodiploid cells in permeabilized, propidium-
stained cells [12]. However, the nuclear morphology of
zVAD-fmk-, paracetamol-exposed cells was abnormal
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Fig. 3. Lactacystin partially prevents the decrease in Bcl-xL expression
and prevents features of apoptosis.. MCT cells were treated with 300
lg/mL paracetamol and/or lactacystin 10 lmol/L for 24 hours. Bcl-xL
expression and apoptosis were studied. (A) Representative Western
blot. Diagram represents mean ± SEM of three Western blots. Data
were normalized for tubulin expression. ADUis arbitrary densitometry
units. (B) Apoptosis was studied by flow cytometry of permeabilized,
propidium iodide–stained cells at 24 hours (mean ± SEM). ∗P < 0.05
versus other groups.
(Fig. 5A). Overexpression of the viral protein CrmA
only delayed paracetamol-induced apoptosis (Fig. 5B).
By contrast, specific inhibitors of caspases-2, -3 and -9
(zVDVAD-fmk, zDEVD-fmk, and zLEHD-fmk, respec-
tively) did not prevent apoptosis (data not shown).
Bcl-xL, but not inhibitors of caspases, increase long-term
cell survival after exposure to paracetamol
Some lethal stimuli can induce both caspase-dependent
apoptosis, and, if caspases are inhibited, eventual caspase-
independent cell death. Caspase inhibition may not im-
prove long-term cell survival when apoptosis is induced
by these stimuli [24, 25]. We tested the ability of Bcl-
xL overexpression and zVAD-fmk to increase long-term
MCT cell survival. Bcl-xL overexpressing cells were able
to adhere to culture substrata and proliferate after treat-
ment with paracetamol, while zVAD-fmk–treated cells
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Fig. 4. Bcl-xL overexpression protects from paracetamol-induced
apoptosis. (A) MCT-transfected cells overexpress Bcl-xL but not Bcl-xS.
Western blot. (B) Data were normalized for tubulin expression. ADU is
arbitrary densitometry units. (C) Bcl-xL-overexpressing cells were pro-
tected from apoptosis induced by paracetamol when compared with
control cells. Apoptosis was studied by flow cytometry of permeabi-
lized, propidium iodide–stained cells. Data are expressed as percentage
of specific protection, where paracetamol-specific cell death was consid-
ered to be 100% in control MCT cells. Mean ± SEM. ∗P < 0.05 versus
control. Data represent three independent experiments.
were not (Fig. 6). The same negative results were ob-
served when specific inhibitors for caspase-8 (zIETD-
fmk), -2, -9, and -3 were used (data not shown).
Bax is not involved in paracetamol-induced cell death
In contrast to Bcl-xL, Bax is a proapoptotic member
of the Bcl-2 family. In normal conditions Bax resides in
the cytoplasm of the cells. Some apoptotic stimuli in-
duce its translocation to the mitochondrial outer mem-
brane where it antagonizes the protecting effect of Bcl-xL
and promotes apoptosis. No changes in bax mRNA ex-
pression were noted after the addition of paracetamol
(Fig. 7A). Also, Bax protein expression did not signifi-
cantly change from 8 hours to 48 hours incubation with
paracetamol, as assessed by Western blot (Fig. 7B). Fur-
thermore, we did not detect any translocation of Bax to
the mitochondria of MCT cells treated with paraceta-
mol (Fig. 7C). Our group has previously shown that this
apoptotic pathway is active in MCT cells [19]. In addi-
tion, suppression of Bax protein expression by means of
Bax antisense ODNs was not protective (a method previ-
ously used in our laboratory to successfully inhibit MCT
cell death induced by other nephrotoxins [19]) (Fig. 7D).
DISCUSSION
The understanding of the apoptotic pathways activated
in the course of tubular cell death induced by different
stimuli may provide the basis for the therapeutic targeting
of apoptosis in the course of acute or chronic renal injury.
Nephrotoxins such as paracetamol engage several molec-
ular pathways for apoptosis, including loss of protective
intracellular molecules and activation of caspases. The
present study shows that the protective protein Bcl-xL
plays a role in paracetamol-induced apoptosis in murine
kidney tubular epithelial cells. They further pinpoint Bcl-
xL as a potential therapeutic target, as opposed to cas-
pases or Bax, for certain forms of tubular injury, such as
paracetamol injury.
Three main molecular pathways for apoptosis have
been described. They are initialed by deprivation of sur-
vival factors, by activation of death receptors or by the
presence of other causes of cellular stress, such as nephro-
toxins (reviewed in [9]). The role of Bcl-xL in the regu-
lation of apoptosis initiated by deprivation of survival
factors or by lethal cytokines, such as tumor necrosis fac-
tor (TNF), has been previously explored in renal tubular
epithelium [14]. In both pathways, there is a decrease in
the expression of bcl-xL mRNA and protein [14]. More-
over, loss of Bcl-xL protein expression was noted in some
tubular epithelial cells during experimental toxic acute
renal failure induced by a folic acid overdose [14]. We
now report that a nephrotoxic drug decreases Bcl-xL in
apoptotic tubular epithelium. These findings suggest that
a decrease in Bcl-xL levels is a common event in tubular
cell death induced by different mechanisms and point to
Bcl-xL as a therapeutic target in nephrotoxicity and other
forms of tubular injury. Indeed, overexpression of Bcl-xL
protected from paracetamol-induced apoptosis and, as
previously reported also protects against TNF-induced
apoptosis [14]. Naturally occurring compensatory over-
expression of Bcl-xL was observed in some tubular cells
in an in vivo model of acute renal failure characterized
by spontaneous recovery of tubular integrity [14].
Paracetamol decreased Bcl-xL protein without signifi-
cantly changing its mRNA levels. Caspases are able to
degrade Bcl-xL in the course of apoptosis, generating
proapoptotic fragments that may contribute to cell death
[17]. However, inhibition of caspases did not prevent the
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Fig. 5. Effect of peptide and viral inhibitors
of caspases on paracetamol-induced apopto-
sis. (A) Although zVAD-fmk prevents nu-
clear morphologic features of apoptosis, it
does not preserve normal nuclear morphol-
ogy. Arrowheads show that the nuclear mor-
phology of zVAD-fmk + paracetamol-treated
cells is different to that characteristic of apop-
totic paracetamol-treated cells (arrows show
condensed, shrunk, picnotic nuclei). How-
ever, it also differs to that of control cells
(hematoxylin and eosin, original magnifica-
tion ×400). Apoptotic cell death at the indi-
cated conditions is also shown (flow cytometry
of permeabilized, propidium iodide–stained
cells). (B) Effect of CrmA on apoptosis in-
duced by paracetamol. Mean ± SEM. ∗P <
0.05 versus control. Apoptosis was quantified
by flow cytometry analysis of DNA content
in permeabilized, propidium iodide–stained
cells. Data represent three independent ex-
periments.
decrease in Bcl-xL in MCT cells exposed to paracetamol.
This raises the possibility of the involvement of other pro-
teases in Bcl-xL degradation in this system [26–28]. The
role of proteasome activation in apoptosis is cell- and
stimulus-specific [29–31]. In different settings, in nonre-
nal cells, the proteasome contributes to the degradation
of specific Bcl-2 family members, and its net effect on
apoptosis induction may depend on whether it regulates
proapoptotic (such as tBid and Bik) or antiapoptotic Bcl-
2-like proteins (such as Bcl-2) [29–34]. In this regard, our
data suggest that the overall effect of proteasome inhibi-
tion in tubular cells may result in protection from apop-
tosis. This information may be relevant to the recently
published observation that the proteasome inhibitor lac-
tacystin protects renal tubular cells in vivo from acute
ischemic damage [35].
Bcl-xL is thought to function either by directly
inhibiting Apaf-1–mediated activation of caspase-9 or
by attenuating release of mitochondrial cytochrome c
through interaction with Bax [16, 36, 37]. Caspases are
cysteine proteases that participate in the initiation and
execution phases of the apoptotic program [38]. During
apoptosis caspase zymogens are activated sequentially
by proteolysis. Caspase-9 becomes activated in a protein
complex formed by Apaf-1 and cytochrome c, following
Fig. 6. Bcl-xL, but not inhibitors of caspases, preserve long-term sur-
vival of paracetamol-treated tubular cells. Bcl-xL-MCT and control
MCT cells were exposed to 300 lg/mL paracetamol for 48 hours, in the
presence or absence of zVAD-fmk, then trypsinized, washed, seeded
in Petri dishes, and allowed to grow for 7 days, then they were stained
with crystal violet. Bcl-xL overexpression, but not caspase inhibition,
increased the number of long-term surviving cell colonies. Data are
representative of three independent experiments.
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Fig. 7. Bax is not involved in MCT paracetamol-induced apoptosis. (A) No change in the expression of bax mRNA was noted after 48-hour culture
in the presence of 300 lg/mL paracetamol. Northern blot. (B) Bax protein expression did not significantly change from 8 hours to 48 hours following
the addition of 300 lg/mL paracetamol, as assessed by Western blot. (C) Confocal microscopy revealed that Bax (green fluorescence) did not
translocate to mitochondria in response to paracetamol. Orange fluorescence is nuclei stained with propidium iodide. Note aggregated Bax in cells
exposed to cyclosporine A (CsA), 10 lg/mL for 24 hours (arrows) (magnification 360×). (D) Suppression of Bax protein expression by means of Bax
antisense oligodeoxynucleotides (ODNs) did not prevent paracetamol-induced apoptosis at 24 hours. Apoptosis was quantified by flow cytometry
analysis of DNA content in permeabilized, propidium iodide–stained cells. ∗P < 0.05 versus CsA alone. CsA was used as a positive control because
it induces MCT cell death with Bax traslocation and Bax antisense ODNs efficiently protect MCT from cell death caused by this nephrotoxin [19].
Data represent three independent experiments.
release of the latter from mitochondria [38]. Caspase-
12 may also activate caspase-9 in the absence of cy-
tochrome c release [39]. Caspase-9, in turn, activates
downstream effector caspases such as caspase-3 [38]. We
have previously reported that caspase-3, -9, and the spe-
cific endoplasmic reticulum stress-activated caspase-12
are activated during MCT paracetamol-induced apopto-
sis [12]. ZVAD-fmk, a broad-spectrum peptide inhibitor
of caspases, prevented paracetamol-induced nuclear fea-
tures of apoptosis [12]. This property is not shared by
specific inhibitors of caspases-3 and -9, suggesting that
activation of these specific caspases is not central for the
development of apoptosis induced by paracetamol. These
findings contrast to the necessary role of caspases-9 and -
3 in cyclosporine A (CsA)-induced apoptosis in the same
cells [19]. In extrarenal cells zVAD-fmk blocks death
receptor-mediated apoptosis and eventual cell death by
preventing the first step of this pathway, caspase-8 activa-
tion [38]. By contrast, in some forms of apoptosis zVAD-
fmk retards cytolysis, but is incapable of preventing dis-
ruption of the plasma membrane during protracted cell
culture, even in conditions in which it completely blocks
600 Lorz et al: Role of Bcl-xL in paracetamol-induced cell death
nuclear apoptosis (chromatin condensation and DNA
fragmentation), leading to a loss of clonogenicity [24,
26]. In this sense, in tubular epithelial cells treated with
paracetamol, zVAD-fmk did not promote long-term sur-
vival. In addition CrmA, a potent and selective inhibitor
of group I caspases (caspase-1, -4, and -5) and most group
III caspases (caspase-8, -9, and -10) [40] afforded only
partial, transitory protection from paracetamol-induced
apoptosis. These results are in contrast with the long-term
protection and maintenance of proliferative potential af-
forded by caspase-3 and -9 specific inhibitors to MCT
cells treated with the nephrotoxin CsA [19]. The failure
of specific caspase-9 inhibitors to prevent apoptosis and
the failure of pancaspase inhibition to promote long-term
cell survival suggests that caspase inhibition is not the ba-
sic mechanism of the protective effect of Bcl-xL. The ob-
served protective effect of Bcl-xL on clonogenicity and
the lack of effect of caspase inhibition despite the disap-
pearance of features of apoptosis is reminiscent of the
effects of Bcl2 in other models of cell death [24].
Bcl-xL may also prevent cytochrome c release from
mitochondria [16]. For this protective function, interac-
tion with the lethal factor Bax and the relative levels of
expression of Bcl-xL and Bax are important [37]. Bax
resides in the cytoplasm of healthy cells. Certain apop-
totic stimuli, such as CsA in tubular epithelium, induce
the translocation of Bax to the mitochondria, where it
promotes the release of cytochrome c to the cytoplasm,
contributing to the formation of the apoptosome, which
leads to the activation of caspase-9 [19]. However, Bax
expression was not increased in tubular cells treated with
paracetamol and no translocation of Bax to mitochondria
was observed. Furthermore, suppression of Bax protein
expression by means of Bax ODNs, an approach that
successfully rescued MCT cells from CsA-induced cell
death [19], did not affect paracetamol toxicity. These re-
sults, together with the lack of cytochrome c release from
mitochondria during paracetamol-induced apoptosis of
tubular epithelium [12], suggest that there is not a role
for Bax in paracetamol toxicity in murine tubular cells
and that the protective effect of Bcl-xL is not related to
its ability to interact with Bax or prevent mitochondrial
events.
Paracetamol induces features of endoplasmic reticu-
lum (ER) stress in tubular epithelium [12]. ER stress
has recently emerged as an apoptosis inducer (reviewed
in [41]). Depending on the apoptotic stimulus, multiple
signalling pathways could emerge from the ER to pro-
mote cell death via caspase-dependent and -independent
means [41]. There are possible roles for Bcl2- related
proteins, such as Bax in these processes [41]. However,
the lack of long-term protection by caspase inhibition or
anti-Bax strategies in this model indicates that additional,
Bcl-xL–sensitive pathways are important. In this regard,
recent papers have described the interaction of Bcl-xL
with a series of apoptotic regulatory proteins located at
the ER. These proteins include, but may not be limited
to, BAP31, RTN-XS, and NSP-C, and ER-specific BH3-
only family members such as Spike [42–44]. The precise
consequences of these interactions have not been fully
characterized yet.
While most research in the pathogenesis of paraceta-
mol and analgesic-induced renal injury has focused on
adverse effects to the renal medulla, both clinical ev-
idence of proximal tubular injury [2, 3, 7] and recent
cell culture data [12], including the present report, in-
dicate that other parts of the nephron may be the tar-
get of the drug. The present manuscript contributes to
further understanding nephrotoxin-specific pathways in
cell death of tubular epithelium. Bcl-xL protects murine
tubular epithelial cells from paracetamol-induced apop-
tosis. In this regard, Bcl-xL appears to protect cultured
tubular cells from lethal stimuli ranging from death re-
ceptor engagement to nephrotoxin exposure. This points
to Bcl-xL as a therapeutic target in nephrotoxicity and
other forms of tubular injury. However, the protective
effect of Bcl-xL on paracetamol toxicity appears to dif-
fer from canonical Bcl-xL actions on caspase-dependent
and Bax-dependent pathways and may be related to ER-
stress specific pathways.
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